- Open Access
- Open Peer Review
Underutilisation of routinely collected data in the HIV programme in Zambia: a review of quantitatively analysed peer-reviewed articles
Health Research Policy and Systems volume 15, Article number: 51 (2017)
The extent to which routinely collected HIV data from Zambia has been used in peer-reviewed published articles remains unexplored. This paper is an analysis of peer-reviewed articles that utilised routinely collected HIV data from Zambia within six programme areas from 2004 to 2014.
Articles on HIV, published in English, listed in the Directory of open access journals, African Journals Online, Google scholar, and PubMed were reviewed. Only articles from peer-reviewed journals, that utilised routinely collected data and included quantitative data analysis methods were included. Multi-country studies involving Zambia and another country, where the specific results for Zambia were not reported, as well as clinical trials and intervention studies that did not take place under routine care conditions were excluded, although community trials which referred patients to the routine clinics were included. Independent extraction was conducted using a predesigned data collection form. Pooled analysis was not possible due to diversity in topics reviewed.
A total of 69 articles were extracted for review. Of these, 7 were excluded. From the 62 articles reviewed, 39 focused on HIV treatment and retention in care, 15 addressed prevention of mother-to-child transmission, 4 assessed social behavioural change, and 4 reported on voluntary counselling and testing. In our search, no articles were found on condom programming or voluntary male medical circumcision. The most common outcome measures reported were CD4+ count, clinical failure or mortality. The population analysed was children in 13 articles, women in 16 articles, and both adult men and women in 33 articles.
During the 10 year period of review, only 62 articles were published analysing routinely collected HIV data in Zambia. Serious consideration needs to be made to maximise the utility of routinely collected data, and to benefit from the funds and efforts to collect these data. This could be achieved with government support of operational research and publication of findings based on routinely collected Zambian HIV data.
Worldwide, many countries routinely collect data on HIV care and services, which is then used to provide national and international indicators about the HIV epidemic. These indicators provide information and insight to aid policymakers and planners when making important decisions about HIV services, to request for further research, and in advocacy for new initiatives and funding [1, 2].
Sub-Saharan Africa is home to approximately 71% of the people living with HIV . Zambia is a high HIV burden country within sub-Saharan Africa, having a national HIV prevalence of 11.6% and almost 980,000 people living with HIV in 2016 [4,5,6]. The HIV epidemic in Zambia is generalised and is mainly attributed to unprotected heterosexual activity . This creates a need to monitor the HIV epidemic by focusing on indicators of effective prevention and on the quality of the HIV services in Zambia . Six key service areas are prioritised in the country for prevention and treatment of HIV. These are (1) voluntary medical male circumcision (VMMC); (2) condom programming; (3) behavioural change; (4) HIV testing and counselling (HTC); (5) prevention of mother-to-child transmission (PMTCT); and (6) treatment and retention in care . At national level, these programmes are monitored using routinely collected data and periodic country representative surveys.
Routinely collected data can also be used to understand the effectiveness of services and to improve decision-making in the healthcare system. The benefits in using routinely collected data include wider coverage of recorded items from across the whole country and the longitudinal nature of the data allowing estimation of trends and changes in the use of services . The use of these data in this way is cost effective, as it is already collected and readily available for analysis. Therefore, research can be conducted in a timely and cost-efficient manner . It can be the basis of sampling for clinical trials, cohort studies and case-control studies, as matched case-control analyses can be performed repeatedly over long time periods . Routinely collected data are usually clinic based, but results from analysis of such data can be generalisable to the whole population if the services are widely used and serve all sections of society . One of the main data collection systems for the routine collection of data from the HIV programme is SmartCare, which is one of the largest electronic patient monitoring systems (PMS) in Africa and is used in South Africa and Ethiopia . In Zambia, the SmartCare database is used as a PMS for HIV services, and the data are used to monitor and plan improvements in the country’s HIV programme. SmartCare has been used as a pilot since 2004, and was officially rolled out in 2006 , with 528 clinics using SmartCare in 2012, and implemented in more than 700 clinics that provide antiretroviral therapy services by 2013 [14, 15]. SmartCare data, in facilities where it is available, is used to provide aggregate reports for DHIS2, and other health management information systems at the district level. In some health facilities, the SmartCare data can inform the drug ordering and the laboratory information systems, but this is not possible in most health facilities in Zambia.
Research has revealed that countries like Zambia, with one of the highest HIV/AIDS prevalence rates in Africa, are not the largest contributors to research on HIV/AIDS. This was evident in a review of three journals focusing on HIV/AIDS , which showed that the United States of America and Western Europe accounted for 85% of all published articles between 1986 and 2003. In sub-Saharan Africa, 50% of all publications on Africa indexed in PubMed between 1981 and 2009 were from South Africa, Uganda and Kenya. Zambia was ranked seventh, with 922 publications within that period, translating to approximately 32 publications per year . This paper is a review of published studies using routinely collected HIV data from Zambia from 2004 to 2015, within the six areas of focus (VMMC, condom programming, behavioural change, HTC, PMTCT, and treatment and retention in care). We sought to examine the extent to which routinely collected HIV data has been analysed quantitatively for publication and identify gaps that exist across the six prioritised areas. It is hoped that findings from this review will potentially inform guidelines and strategies as well as stimulate policy dialogue in the use of routinely collected data.
Literature search strategy
We conducted a literature review of studies that reported results from routinely collected HIV data in Zambia. We utilised a detailed search protocol and standard systematic review procedures (Additional file 1) for papers which utilised routinely collected HIV data from primary to tertiary healthcare settings, using SmartCare or other electronic or paper-based PMS data in Zambia. We included studies published between 2004 (when SmartCare started) and November 2015. The search was conducted between July and November 2015. We selected only original articles from peer-reviewed journals on HIV studies conducted in Zambia utilising routinely collected data and quantitative methods of data analysis. All reported studies relevant to our search topic were reviewed, regardless of sample size. Articles were excluded if they were not written in English or where the specific results for Zambia were not reported from regional or multi-country studies. Clinical trials and intervention studies that did not take place under routine care conditions were also excluded, although community trials that referred patients to the routine clinics were included.
We searched the PubMed, Google Scholar, Directory of Open Access Journals, and African Journals Online databases for articles on HIV in Zambia that utilised routinely collected data (Table 1). We used a combination of search words that included “HIV”, “SmartCare” and “routinely collected data”, among others (Table 1). One of the authors (TM) searched for articles and extracted the data from included studies, while another author (SG) reviewed the extracted data for discrepancies. All discrepancies were discussed and resolved. A standard data extraction form was used to review and extract data such as sample size, study design, number of study sites, dates of data collection, year of publication and main outcomes.
The selected papers could only be categorised by the six programme areas as the range of topics covered prevented aggregated statistical analysis of findings. All eligible articles were further grouped by the populations used in the papers, namely adult (males and females above 15 years of age), women and children (under the age of 15 years) to assess how effectively the priority areas cover the different age categories. The eligible articles were also analysed based on institutions that collaborated to publish the articles.
A total of 1846 titles were reviewed and 1048 were excluded because they were not published in journals (n = 482), were published before 2004 (n = 335), or the topics were not relevant (n = 231). A total of 791 abstracts were then reviewed. Of these, some were excluded because they were clinical trials (n = 39), qualitative studies (n = 110), or did not use routinely collected data (n = 470), or were multi-country studies that did not include specific data on Zambia (n = 103) (Fig. 1). From these, 69 full length articles were selected, of which seven were found to be multi-country studies that did not use routinely collected data, and the remaining 62 were considered for categorisation. The articles were then classified into the six HIV service areas.
Overall, 15 articles addressed PMTCT, four focussed on HTC, four covered social and behavioural change (Table 2), and 39 covered treatment and retention in care. Our search did not reveal any articles that used routinely collected HIV data in Zambia reporting outcomes in the areas of condom programming or VMMC utilising quantitative methods.
The majority of the papers were mostly large samples, with thousands of subjects, covering many different health facilities. The articles on HIV treatment and retention in care covered topics such as enrolment and retention into antiretroviral therapy, effectiveness of different drug regimens, coinfections with laboratory confirmed pathogens, comorbidities using clinical signs and symptoms, and food supplementation (Table 3). The 15 PMTCT articles found addressed elimination of paediatric HIV infections, transmission of HIV to the babies, and improvement of survival in infected mothers and their exposed children.
We found four articles on HTC covering couple counselling and provider-initiated testing and counselling. Articles on social and behaviour change looked at creating demand for adherence, prevention interventions, improved biomarkers and treatment uptake. Treatment and care had the largest number of articles with 39 articles covering the topic (Table 3). Of the 62 articles, 33 full length papers utilised adult only routinely collected data and addressed retention in care, access to HIV treatment, mortality and clinical outcomes. A total of 16 full-length articles used data from only women, covering contraception, PMTCT and antenatal HIV prevalence rates. The articles using data on women only were published between 2010 and 2011, and had sample sizes ranging from 1435 to 138,884. There were 13 peer-reviewed articles that addressed paediatric HIV care and treatment. These were published between 2007 and 2013, with sample sizes ranging from 1120 to 4975. Our search did not reveal any articles utilising routinely collected HIV data specifically on adolescents aged 10–24 years old.
The 62 papers analysed were published in collaboration with partner institutions (Fig. 2). The Centre for Infectious Disease Research in Zambia and the University of Alabama had the highest contribution, with collaboration on 42 and 29 papers, respectively. The staff from national and district levels of the Ministry of Health participated in 40 of the published articles, while the lower collaboration was from institutions based in the United Kingdom, with collaboration on only 8 articles, four from LSHTM and four from other universities.
The review of published articles showed that considerable strides are being made in utilisation of routinely collected HIV data in Zambia. A total of 62 articles were found and considered in this review. Treatment and retention in care and PMTCT had the highest contribution, with counselling and social and behavioural change having four articles each. However, we could not find published papers that utilised quantitative data analysis methods in our search on VMMC and condom programming despite the importance of these programmes and the inclusion of data from these programmes in SmartCare. The broad focus of the literature search on HIV in Zambia should have identified many papers on condom programming or VMMC, but the only papers found were qualitative studies on these topics. It was also observable during the search process that quantitatively analysed studies on HIV in adolescents in the country were limited and information for this age group has to be extracted from paediatric and adult studies.
This study was a collection of articles covering a diverse range of topics, which meant that no meta-analysis of the studies was possible. One of the goals of this paper was to highlight the range and diversity of the topics available for analysis using routinely collected data, and to explore the gaps in the published literature so far. The main topics were grouped into treatment and retention in care, PMTCT, HTC, condom programming and VMMC. Our search on VMMC and condom programming revealed no quantitatively analysed papers and few qualitatively analysed papers.
We did not include a large number of qualitatively analysed, clinical trial and survey-based articles, which have made important contributions to policy change in HIV care and treatment in Zambia. Further, risk of bias in individual study papers selected was not prioritised during the selection process since the rationale of the review was to assess the extent of utilisation of routinely collected data in the country. Only peer-reviewed articles where included because the assumption was that the peer-review process implies some form of quality control for biases in selected papers. In addition, only one of the authors reviewed the titles and abstracts, which could be a source of bias. However, as far as we are aware, this is the first study to provide such a baseline of studies for future referral.
The total number of published articles found in our literature search on the six HIV programmatic areas using routinely collected data meeting our criteria was quite low (an average of six articles per year) considering that these have been published in the past 10 years. This finding is lower than the 32 articles per year reported by Uthman , but in line with findings by the Ministry of Health , where the use and analysis of routinely collected data were found to be inadequate in Zambia, with analysed data displayed in graphs and information from the districts rarely used for decision-making at district levels. The reasons for these low numbers could be the limited data analysis skills, unavailability of data analysis software, disapproval or lack of support from supervisors, and lack of time and opportunity [9,10,11, 18,19,20]. It could be further argued that the limited use of routinely collected data was due to lack of knowledge on the benefits of analyzing such data at facility and district levels and poor data management, which could be alleviated by deliberate policy from government to support existing staff capacity building, operational research and publication of findings [18, 21].
Treatment and retention in care had the largest number of studies. This is in line with global trends in HIV prevention strategies where treatment and retention in care have been identified as the most effective HIV prevention tool among the biomedical prevention tools analysed to date [22, 23]; more research is encouraged in these areas. However, considering the period under review, the number of studies found on retention and care were rather low. Similar trends of low levels of publication in this area have been attributed to long follow-up periods required to monitor retention in care as well as to inconsistent information systems that make it difficult to track patients that seek care from multiple facilities .
There was also a limited number of studies that looked at children born with HIV infection identified in our search. This is in line with findings from a systematic review of care and retention in HIV-infected children in low- and middle-income countries, where limited data were also found in Asia, Eastern Europe and Latin America , attributed to emphasis on studies on adult data. It was also apparent that no quantitative peer-reviewed studies on treatment and retention among adolescents already in HIV care in Zambia were found in our search. Data on this age group has to be extracted from paediatric and adult studies. Similar findings have been reported in studies conducted in southern Africa in 2009  and 2010 , where few data were reported on perinatally infected adolescents with most of the available data on adherence and outcomes emerging from the developed world. It is further argued that data for adolescents in southern Africa are disaggregated into 0–14, 15–19 and 15–24 year age groups, which makes it difficult to ascertain adolescent-specific data since, in most cases, the data includes very young children or adults .
The search on condom programming revealed mostly intervention studies in settings where prospective users could access them. Reasons for this could be the mode of distribution, which is restricted to public health facilities and to private health facilities only on request . Similarly, Kane et al.  argued that use of aggregate data on condom sales does not provide information on utilisation of condoms after they are obtained, resulting in the need for in-depth analysis on factors associated with condom use. The same could be concluded on usefulness of aggregate condom distribution data. Moreover, condom distribution data are difficult to document in routinely collected data and thus there is heavy reliance on survey data . There is an urgent need to understand the demographics of condom distribution in the country. Similar trends were revealed in the VMMC programme, which also yielded low numbers of peer-reviewed articles that utilised routinely collected quantitative data, despite the country not meeting its circumcision targets .
There are positive advances being made in the HIV programme in the use of routinely collected data in Zambia. This progress must be nurtured and enhanced if Zambia is to reach elimination stages in HIV control. However, more efforts must be put into research and publishing results in critical areas, such as paediatric and adolescent care, VMMC and condom distribution, in order to build the skills and knowledge-base to deliver HIV services. Research on adolescent and childhood HIV morbidity and mortality outcomes as well as social behavioural change needs is important because HIV-infected adolescents and children are the key population in reducing HIV spread in their generation.
To improve the use of routinely collected data for use in publications the government could deliberately put in place policies to prioritise training of civil servants working in various programmes in operational research and consequently fund publishing of findings. These published articles would aid in international resource mobilisation for most programmes in the country as programme level data can be easily accessed in peer-reviewed articles.
HIV testing and counselling
patient monitoring system
prevention of mother to child transmission
voluntary male circumcision
World Health Organization. Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: WHO; 2015.
World Health Organization. National AIDS Programmes: A Guide to Indicators for Monitoring and Evaluating National Antiretroviral Programmes. Geneva: WHO; 2005.
UNAIDS. The Gap Report. Geneva: UNAIDS; 2014.
National HIVAIDS Council Zambia; Zambia Country Report: Monitoring the Declaration of Commitment on HIV and AIDS and the Universal Access, The United Nations General Assembly Special Session on HIV and AIDS. Lusaka: Republic of Zambia; 2014.
UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. Geneva: UNAIDS; 2013.
Ministry of Health. Zambia Population-Based HIV Impact Assessment (ZAMPHIA) 2015–2016, Summary Sheet: Preliminary Findings. Lusaka: Ministry of Health; 2016.
Ministry of Health. National AIDS Strategic Framework 2014-2016: A Nation Free from the Threat of HIV and AIDS. Lusaka: Ministry of Health; 2014.
Central Statistical Office, Ministry of Health, and ICF International. Zambia Demographic and Health Survey 2013–14. Rockville: CSO, MoH, and ICF Int; 2014.
Deeny SR, Steventon A. Making sense of the shadows: priorities for creating a learning healthcare system based on routinely collected data. BMJ Qual Saf. 2015;24(8):505–15.
Grzeskowiak LE, Gilbert AL, Morrison JL. Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy. Ther Adv Drug Saf. 2013;4(1):27–37.
Bain MR, Chalmers JW, Brewster DH. Routinely collected data in national and regional databases-an under-used resource. J Public Health. 1997;19(4):413–8.
Tassie J-M, Malateste K, Pujades-Rodríguez M, Poulet E, Bennett D, Harries A, Mahy M, Schechter M, Souteyrand Y, Dabis F. Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low-and middle-income countries. PLoS One. 2010;5(11):e13899.
Ministry of Health. National Health Report, Directorate of Public Health and Research. Lusaka: MoH; 2012.
Ministry of Health. List of Health Facilities in Zambia, Preliminary Report. Lusaka: MoH; 2013.
PEPFAR. Zambia Operational Plan Report FY 2013. Washington, DC: PEPFAR; 2013. https://www.pepfar.gov/documents/organization/222188.pd. Accessed July 2015.
Uusküla A, Toompere KLK, et al. HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis. BMJ Open. 2015;5(2):e006591.
Uthman OA. Pattern and determinants of HIV research productivity in sub-Saharan Africa: bibliometric analysis of 1981 to 2009 PubMed papers. BMC Infect Dis. 2010;10:47.
Ministry of Health. Assessment of the Health Information System in Zambia. Lusaka: Ministry of Health, Department of Planning and Development, Monitoring and Evaluation Unit; 2007.
Zachariah R, Ford N, Maher D, Bissell K, Van den Bergh R, van den Boogaard W, Reid T, Castro KG, Draguez B, von Schreeb J. Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis. 2012;12(5):415–21.
Torpey K, Kabaso M, Kasonde P, Dirks R, Bweupe M, Thompson C, Mukadi Y. Increasing the uptake of prevention of mother-to-child transmission of HIV services in a resource-limited setting. BMC Health Serv Res. 2010;10:29.
Jorm L. Routinely collected data as a strategic resource for research: priorities for methods and workforce. Public Health Res Pract. 2015;25(4):e2541540.
UNAIDS. 90-90-90: An Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva: UNAIDS; 2014.
World Health Organization. Treat all people living with HIV, offer antiretrovials as additional prevention choice for people at “substantial risk”. 2015. http://www.who.int/mediacentre/news/releases/2015/hiv-treat-all-recommendation/en/. Accessed Oct 2015.
Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056.
Fox MP, Rosen S. Systematic review of retention of pediatric patients on HIV treatment in low and middle-income countries 2008–2013. AIDS. 2015;29(4):493–502.
Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in Southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65–71.
Gray GE. Adolescent HIV? Cause for concern in Southern Africa. PLoS Med. 2010;7(2):e1000227.
Hervish A, Clifton D. Status Report: Adolescents and Young People in Sub-Saharan Africa. Opportunities and Challenges. 2012. www.prb.org/pdf12/status-report-youth-subsaharan-Africa.pdf. Accessed July 2015.
Sandøy IF, Zyaambo C, Michelo C, Fylkesnes K. Targeting condom distribution at high risk places increases condom utilization-evidence from an intervention study in Livingstone, Zambia. BMC Public Health. 2012;12:10.
Kane R, Wellings K, Free C, Goodrich J. Uses of routine data sets in the evaluation of health promotion interventions: opportunities and limitations. Health Educ. 2000;100(1):33–41.
Topp SM, Li MS, Chipukuma JM, Chiko MM, Matongo E, Bolton-Moore C, Reid SE. Does provider-initiated counselling and testing (PITC) strengthen early diagnosis and treatment initiation? Results from an analysis of an urban cohort of HIV-positive patients in Lusaka, Zambia. J Int AIDS Soc. 2012;15(2):17352.
Topp SM, Chipukuma JM, Chiko MM, Wamulume CS, Bolton-Moore C, Reid SE. Opt-out provider-initiated HIV testing and counselling in primary care outpatient clinics in Zambia. Bull World Health Organ. 2011;89(5):328–35.
Czaicki NL, Davitte J, Siangonya B, Kastner R, Ahmed N, Khu NH, Kuo WH, Abdallah J, Wall KM, Tichacek A, et al. Predictors of first follow-up HIV testing for couples’ voluntary HIV counseling and testing in Ndola, Zambia. J Acquir Immune Defic Syndr. 2014;66(1):e1–7.
Kankasa C, Carter RJ, Briggs N, Bulterys M, Chama E, Cooper ER, Costa C, Spielman E, Katepa-Bwalya M, M'soka T, et al. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. JAIDS J Acquir Immune Defic Syndr. 2009;51(2):202–8.
Killam WP, Tambatamba BC, Chintu N, Rouse D, Stringer E, Bweupe M, Yu Y, Stringer JS. Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation. AIDS. 2010;24(1):85–91.
Stringer EM, Sinkala M, Stringer JS, Mzyece E, Makuka I, Goldenberg RL, Kwape P, Chilufya M, Vermund SH. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS. 2003;17(9):1377.
Stringer JS, Sinkala M, Maclean CC, Levy J, Kankasa C, DeGroot A, Stringer EM, Acosta EP, Goldenberg RL, Vermund SH. Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS. 2005;19(12):1309.
Chibwesha CJ, Giganti MJ, Putta N, Chintu N, Mulindwa J, Dorton BJ, Chi BH, Stringer JS, Stringer EM. Optimal time on HAART for prevention of mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011;58(2):224.
Liu KC, Mulindwa J, Giganti MJ, Putta NB, Chintu N, Chi BH, Stringer JS, Stringer EM. Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2011;57(5):e101.
Chintu N, Giganti MJ, Putta NB, Sinkala M, Sadoki E, Stringer EM, Stringer JS, Chi BH. Peripartum nevirapine exposure and subsequent clinical outcomes among HIV‐infected women receiving antiretroviral therapy for at least 12 months. Trop Med Int Health. 2010;15(7):842–7.
Mandala J, Torpey K, Kasonde P, Kabaso M, Dirks R, Suzuki C, Thompson C, Sangiwa G, Mukadi YD. Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers. BMC Public Health. 2009;9:314.
Chibwesha CJ, Li MS, Matoba CK, Mbewe RK, Chi BH, Stringer JS, Stringer EM. Modern contraceptive and dual method use among HIV-infected women in Lusaka, Zambia. Infect Dis Obstet Gynecol. 2011;2011:261453.
Stringer EM, Chintu NT, Levy JW, Sinkala M, Chi BH, Muyanga J, Bulterys M, Bweupe M, Megazzini K, Stringer JS. Declining HIV prevalence among young pregnant women in Lusaka, Zambia. Bull World Health Organ. 2008;86(9):697–702.
Mulindwa JM. A study of nevirapine toxicity in HIV infected pregnant women at the University Teaching Hospital in Lusaka, Zambia. Med J Zambia. 2012;39(1):11–5.
Ngoma MS, Misir A, Mutale W, Rampakakis E, Sampalis JS, Elong A, Chisele S, Mwale A, Mwansa JK, Mumba S, et al. Efficacy of WHO recommendation for continued breastfeeding and maternal cART for prevention of perinatal and postnatal HIV transmission in Zambia. J Int AIDS Soc. 2015;18(1):19352.
Torpey K, Mandala J, Kasonde P, Bryan-Mofya G, Bweupe M, Mukundu J, Zimba C, Mwale C, Lumano H, Welsh M. Analysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in Zambia. PLoS One. 2012;7(8):e42859.
Torpey K, Kasonde P, Kabaso M, Weaver MA, Bryan G, Mukonka V, Bweupe M, Zimba C, Mwale F, Colebunders R. Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia. J Acquir Immune Defic Syndr. 2010;54(4):415–22.
Albrecht S, Semrau K, Kasonde P, Sinkala M, Kankasa C, Vwalika C, Aldrovandi GM, Thea DM, Kuhn L. Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission. J Acquir Immune Defic Syndr. 2006;41(1):114–8.
Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Ried SE, Levy JW, Limbada M, Taylor A, Saag MS, Vermund SH, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24(8):1031–5.
Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH. Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr. 2008;47(5):615–22.
Birbeck GL, Chomba E, Kvalsund M, Bradbury R, Mang’ombe C, Malama K, Kaile T, Byers PA, RAAZ Study Team, Organek N. Antiretroviral adherence in rural Zambia: the first year of treatment availability. Am J Trop Med Hyg. 2009;80(4):669–74.
Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, Tambatamba-Chapula B, Levy J, Stringer EM, Mulenga L, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;49(2):190–5. doi:10.1097/QAI.1090b1013e31818455d31818452.
Koethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, Banda Y, Stringer JS. Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2010;53(4):507.
Tirivayi N, Koethe JR, Groot W. Clinic-based food assistance is associated with increased medication adherence among HIV-infected adults on long-term antiretroviral therapy in Zambia. J AIDS Clin Res. 2012;3(7):171.
Koethe JR, Limbada MI, Giganti MJ, Nyirenda CK, Mulenga L, Wester CW, Chi BH, Stringer JS. Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia. AIDS. 2010;24(13):2117.
Stringer JS, Mwango AJ, Giganti MJ, Mulenga L, Levy JW, Stringer EM, Mulenga P, Saag MS, Musonda P, Williams FB. Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study. Int J Epidemiol. 2012;41(2):448–59.
Chi BH, Mwango A, Giganti MJ, Sikazwe I, Moyo C, Schuttner L, Mulenga LB, Bolton-Moore C, Chintu NT, Sheneberger R. Comparative outcomes of tenofovir-and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2011;58(5):475.
Chi BH, Mwango A, Giganti M, Mulenga LB, Tambatamba-Chapula B, Reid SE, Bolton-Moore C, Chintu N, Mulenga PL, Stringer EM. Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia. J Acquir Immune Defic Syndr. 2010;54(1):63.
Chi BH, Giganti M, Mulenga PL, Limbada M, Reid SE, Mutale W, Stringer JS. CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2009;52(1):125.
Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, Limbada M, Mulenga LB, Vermund SH, Stringer JS. An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epidemiol. 2010;171(8):924–31.
Giganti MJ, Limbada M, Mwango A, Moyo C, Mulenga LB, Guffey MB, Mulenga PL, Bolton-Moore C, Stringer JS, Chi BH. Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2012;61(1):120.
Vinikoor MJ, Sinkala E, Mweemba A, Zanolini A, Mulenga L, Sikazwe I, Fried MW, Eron JJ, Wandeler G, Chi BH. Elevated AST‐to‐platelet ratio index is associated with increased all‐cause mortality among HIV‐infected adults in Zambia. Liver Int. 2015;35(7):1886–92.
Mulenga LB, Kruse G, Lakhi S, Cantrell RA, Reid SE, Zulu I, Stringer EM, Krishnasami Z, Mwinga A, Saag MS. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS. 2008;22(14):1821.
Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782–93.
Seu L, Mulenga LB, Siwingwa M, Sikazwe I, Lambwe N, Guffey MB, Chi BH. Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia. J Med Virol. 2015;87(7):1149–57.
Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, Levy J, Sinkala M, Stringer JS. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care. 2008;20(3):311–7.
Vinikoor MJ, Schuttner L, Moyo C, Li M, Musonda P, Hachaambwa LM, Stringer JS, Chi BH. Short communication: late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia. AIDS Res Hum Retroviruses. 2014;30(1):74–7.
Vinikoor MJ, Joseph J, Mwale J, Marx MA, Goma FM, Mulenga LB, Stringer JS, Eron JJ, Chi BH. Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia. AIDS Res Hum Retroviruses. 2014;30(10):949–55.
Harris J, Hatwiinda S, Randels K, Chi B, Kancheya N, Jham M, Samungole K, Tambatamba B, Cantrell R, Levy J. Early lessons from the integration of tuberculosis and HIV services in primary care centers in Lusaka, Zambia. Int J Tuberc Lung Dis. 2008;12(7):773–9.
Mweemba A, Zanolini A, Mulenga L, Emge D, Chi BH, Wandeler G, Vinikoor MJ. Chronic hepatitis B virus coinfection is associated with renal impairment among Zambian HIV-infected adults. Clin Infect Dis. 2014;59(12):1757–60.
Deo S, Topp SM, Westfall AO, Chiko MM, Wamulume CS, Morris M, Reid S. Impact of organizational factors on adherence to laboratory testing protocols in adult HIV care in Lusaka, Zambia. BMC Health Serv Res. 2012;12:106.
Chi BH, Sinkala M, Stringer EM, Cantrell RA, Mtonga V, Bulterys M, Zulu I, Kankasa C, Wilfert C, Weidle PJ. Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS. 2007;21(8):957.
Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, Sinkala M, Kankasa C, Wilson CM, Wilfert CM. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298(16):1888–99.
Mubiana‐Mbewe M, Bolton‐Moore C, Banda Y, Chintu N, Nalubamba‐Phiri M, Giganti M, Guffey MB, Sambo P, Stringer EM, Stringer JS. Causes of morbidity among HIV‐infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia. Trop Med Int Health. 2009;14(10):1190–8.
Scott CA, Iyer H, Bwalya DL, McCoy K, Meyer-Rath G, Moyo C, Bolton-Moore C, Larson B, Rosen S. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis. PLoS One. 2013;8(6):e67910.
Kiage JN, Heimburger DC, Nyirenda CK, Wellons MF, Bagchi S, Chi BH, Koethe JR, Arnett DK, Kabagambe EK. Cardiometabolic risk factors among HIV patients on antiretroviral therapy. Lipids Health Dis. 2013;12:50.
Sutcliffe CG, Bolton-Moore C, van Dijk JH, Cotham M, Tambatamba B, Moss WJ. Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study. BMC Pediatr. 2010;10:54.
Iyer HS, Scott CA, Lembela Bwalya D, Meyer-Rath G, Moyo C, Bolton Moore C, Larson BA, Rosen S. Resource utilization and costs of care prior to ART initiation for pediatric patients in Zambia. AIDS Res Treat. 2014;2014:235483.
Sutcliffe CG, van Dijk JH, Bolton-Moore C, Cotham M, Tambatamba B, Moss WJ. Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural Zambia. Pediatr Infect Dis J. 2010;29(9):849–54.
Sutcliffe CG, Scott S, Mugala N, Ndhlovu Z, Monze M, Quinn TC, Cousens S, Griffin DE, Moss WJ. Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis. 2008;47(6):837–44.
van Dijk JH, Moss WJ, Hamangaba F, Munsanje B, Sutcliffe CG. Scaling-up access to antiretroviral therapy for children: a cohort study evaluating care and treatment at mobile and hospital-affiliated HIV clinics in rural Zambia. PLoS One. 2014;9(8):e104884.
van Dijk JH, Sutcliffe CG, Munsanje B, Sinywimaanzi P, Hamangaba F, Thuma PE, Moss WJ. HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS One. 2011;6(4):e19006.
Sutcliffe C, van Dijk J, Munsanje B, Hamangaba F, Sinywimaanzi P, Thuma P, Moss W. Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. BMC Infect Dis. 2011;11:54.
Nkamba KR-LHC, Moss W, Siziya S. Antimycobacterial immune responses in HIV-infected children starting antiretroviral therapy in Lusaka, Zambia. Med J Zambia. 2010;37(4):216–22.
van Dijk JH, Sutcliffe CG, Munsanje B, Hamangaba F, Thuma PE, Moss WJ. Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis. BMC Infect Dis. 2009;9:169.
Sinkala E, Gray S, Zulu I, Mudenda V, Zimba L, Vermund SH, Drobniewski F, Kelly P. Clinical and ultrasonographic features of abdominal tuberculosis in HIV positive adults in Zambia. BMC Infect Dis. 2009;9:44.
Sheyo M. Clinical outcome of burns in HIV positive patients in Lusaka, Zambia. Med J Zambia. 2012;39(4):1–6.
Brugha R, Simbaya J, Walsh A, Dicker P, Ndubani P. How HIV/AIDS scale-up has impacted on non- HIV priority services in Zambia. BMC Public Health. 2010;10:540.
Kancheya NG, Jordan AK, Zulu IS, Chanda D, Vermund SH. Improved HIV testing coverage after scale-up of antiretroviral therapy programs in urban Zambia: evidence from serial hospital surveillance. Med J Zambia. 2010;37(2):71–7.
Kaile T, Zulu I, Lumayi R, Ashman N, Kelly P. Inappropriately low aldosterone concentrations in adults with AIDS-related diarrhoea in Zambia: a study of response to fluid challenge. BMC Res Notes. 2008;1:10.
We acknowledge the SEARCH Project team in London for the additional training in HIV data analysis and support while in London.
This writing or this paper was supported by the Sustainable Evaluation through Analysis of Routinely Collected HIV data (SEARCH) project Zambia.
Availability of data and materials
The dataset supporting the conclusions of this article is included with the article and its additional files.
TM and PM participated in the conception of the study. SGM reviewed the analysed articles. CM, PM, JT, NK and CP reviewed all the drafts for intellectual content, participated in the interpretation of the findings. The whole team participated in the critical review and editing of all the manuscript drafts for scientific merit and depth. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.